Contact
Please use this form to send email to PR contact of this press release:
FDA Grants Orphan Drug Designation to Surface Oncology’s SRF231 for the Treatment of Multiple Myeloma
TO:
Please use this form to send email to PR contact of this press release:
FDA Grants Orphan Drug Designation to Surface Oncology’s SRF231 for the Treatment of Multiple Myeloma
TO: